BILI arrives at its May 21 Q1 earnings report as one of the most shorted and most tightly borrowed names in the Chinese internet space.
The borrow market tells the most compressed story going into the print. Availability has barely moved above 1% for most of the past month, meaning almost every share in the lending pool is already lent out. That tightness comes alongside a cost to borrow that nearly doubled over the past month — though it has eased to 3.9% after peaking above 6% earlier in May as short sellers rebuilt positions. Short interest climbed roughly 7% on the week to about 5% of free float, and with days to cover running at nearly 10, shorts are not moving quickly. The ORTEX short score of 64 — in the bottom 9th percentile for its sector — and a utilization rank at the 1st percentile confirm this is as squeezed a lending market as you will find. Meanwhile, the stock is down 20% over the past month and off 7% on the week heading into the print, closing at $20.00.
Options positioning adds a modestly cautious signal. The put/call ratio has drifted higher to 0.64, roughly 1.4 standard deviations above its 20-day average of 0.60. That is not extreme — it remains well below the 52-week high of 0.71 — but the direction of travel over the past two weeks is a measured tilt toward downside protection.
The Street has been moving constructively on the name, though the gap between analyst targets and the current price deserves scrutiny. Morgan Stanley upgraded to Overweight in mid-April, lifting its target to $31. JP Morgan made a similar move in late March, shifting to Overweight with a $35 target. Those upgrades put consensus return potential at 63%. The RSI has fallen to 29, a deeply oversold reading by any measure. Bulls point to improving monetization, a 30-day EPS momentum score in the 64th percentile, and a history of beating estimates — BILI's EPS surprise rank sits in the 87th percentile. Bears point to the March earnings reaction, where the stock fell more than 10% in a single session and gave back another point over the following five days, and to structural concerns around competition and Chinese regulatory exposure that have weighed on the sector broadly. The PE has compressed sharply, down more than 5 points over the past 30 days to 16.8x, a sign the market has been de-rating the stock even as analysts upgraded it.
The May 21 print will test whether the company's monetization trajectory can justify the recent wave of upgrades — or whether the borrow squeeze and depressed RSI are symptoms of something the numbers will confirm.
See the live data behind this article on ORTEX.
Open BILI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
